(Q39642164)

13 September 2017

1 reference

title

New antiarrhythmic drugs. (English)

1 reference

13 September 2017

P F Nestico

1

1 reference

13 September 2017

J Morganroth

series ordinal

2

1 reference

13 September 2017

L N Horowitz

series ordinal

3

1 reference

13 September 2017

1 March 1988

1 reference

13 September 2017

1 reference

13 September 2017

35

1 reference

13 September 2017

286-319

1 reference

13 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198835030-00005

13 September 2017

0 references

cites work

Mexiletine for ventricular arrhythmias

1 reference

12 December 2020

Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment

1 reference

12 December 2020

Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: Electrophysiologic effects and results of programmed ventricular stimulation

1 reference

12 December 2020

Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers

1 reference

12 December 2020

Response optimization of drug dosage: antiarrhythmic studies with tocainide

1 reference

12 December 2020

Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring

1 reference

12 December 2020

Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents

1 reference

12 December 2020

Mexiletine for control of drug-resistant ventricular tachycardia: Clinical and electrophysiologic results in 44 patients

1 reference

12 December 2020

Ventricular arrhythmias: use of electrophysiologic studies

1 reference

12 December 2020

Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes

1 reference

12 December 2020

Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes

1 reference

12 December 2020

Amiodarone-induced cornea verticillata.

1 reference

12 December 2020

Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease

1 reference

12 December 2020

Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

1 reference

12 December 2020

Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study

1 reference

12 December 2020

Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia

1 reference

12 December 2020

Acute prolongation of myocardial refractoriness by sotalol

1 reference

12 December 2020

Hemodynamic studies with sotalol in man, performed at rest, during exercise, and during right ventricular pacing

1 reference

12 December 2020

Retroperitoneal fibrosis associated with sotalol.

1 reference

12 December 2020

Studies on the effect of Melixetin (Kö 1173) on AV-conduction time and sinus pulse automation in persons with healthy hearts and in patients with disorders of the impulse-conduction system

1 reference

12 December 2020

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

1 reference

12 December 2020

Clinical electrophysiologic effects of tocainide

1 reference

12 December 2020

1 reference

12 December 2020

Antiarrhythmic and Hemodynamic Actions of Flecainide Acetate (R-818) in the Ischemic Porcine Heart

1 reference

12 December 2020

Long-term tocainide therapy for ventricular arrhythmias

1 reference

12 December 2020

Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia

1 reference

12 December 2020

Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles

1 reference

12 December 2020

Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms

1 reference

12 December 2020

Drug interactions with amiodarone

1 reference

12 December 2020

A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats

1 reference

12 December 2020

Effect of amiodarone in the Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.

1 reference

12 December 2020

Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial

1 reference

12 December 2020

Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.

1 reference

12 December 2020

High-performance liquid chromatographic determination of ethmozin in plasma

1 reference

12 December 2020

Electrophysiology of oral encainide

1 reference

12 December 2020

Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography

1 reference

12 December 2020

Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safety

1 reference

12 December 2020

Effect of Flecainide on Action Potentials and Alternating Current-Induced Arrhythmias in Mammalian Myocardium

1 reference

12 December 2020

Sotalol: A new, safe beta adrenergic receptor blocking agent∗

1 reference

12 December 2020

Amiodarone: Historical development and pharmacologic profile

1 reference

12 December 2020

Tocainide therapy for treatment of ventricular arrhythmias: assessment with ambulatory electrocardiographic monitoring and treadmill exercise

1 reference

12 December 2020

Tocainide-induced ventricular fibrillation

1 reference

12 December 2020

Suppression of ventricular ectopic depolarizations by tocainide

1 reference

12 December 2020

Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.

1 reference

12 December 2020

Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers

1 reference

12 December 2020

Haemodynamic effects of a new anti-arrhythmic agent, mexiletine (Ko 1173) in ischaemic heart disease

1 reference

12 December 2020

Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline

1 reference

12 December 2020

Observations of the haemodynamics of mexiletine

1 reference

12 December 2020

Sotalol-induced delayed ventricular repolarization in man.

1 reference

12 December 2020

Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring

1 reference

12 December 2020

Sotalol kinetics in renal insufficiency

1 reference

12 December 2020

Sotalol prolongation of the QTc interval in hypertensive patients

1 reference

12 December 2020

Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy

1 reference

12 December 2020

Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients

1 reference

12 December 2020

The clinical pharmacology of mexiletine

1 reference

12 December 2020

Disposition of intravenous pirmenol

1 reference

12 December 2020

Ventricular tachycardia associated with flecainide

1 reference

12 December 2020

Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function

1 reference

12 December 2020

Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.

1 reference

12 December 2020

Safety and efficacy of a twice-daily dosing regimen for moricizine (ethmozine)

1 reference

12 December 2020

Comparative Trial of Mexiletine and Lignocaine in the Treatment of Early Ventricular Tachyarrhythmias After Acute Myocardial Infarction

1 reference

12 December 2020

Studies of amiodarone during experimental myocardial infarction: beneficial effects on hemodynamics and infarct size.

1 reference

12 December 2020

Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones

1 reference

12 December 2020

Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent

1 reference

12 December 2020

Amiodarone in refractory life-threatening ventricular arrhythmias

1 reference

12 December 2020

Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias

1 reference

12 December 2020

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 reference

12 December 2020

Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design

1 reference

12 December 2020

Metabolite cumulation during long-term oral encainide administration

1 reference

12 December 2020

Electrophysiological Effects of a New Antiarrhythmic Agent, Flecainide, on the Intact Canine Heart

1 reference

12 December 2020

Cibenzoline plasma concentration and antiarrhythmic effect.

1 reference

12 December 2020

Sotalol, hypokalaemia, syncope, and torsade de pointes

1 reference

12 December 2020

Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide

1 reference

12 December 2020

Amiodarone increases plasma digoxin concentrations

1 reference

12 December 2020

Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia

1 reference

12 December 2020

Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias

1 reference

12 December 2020

Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man.

1 reference

12 December 2020

Interaction between warfarin sodium and amiodarone

1 reference

12 December 2020

A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent

1 reference

12 December 2020

Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs

1 reference

12 December 2020

Observations on the efficacy and pharmacokinetics of sotalol after oral administration

1 reference

12 December 2020

Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties

1 reference

12 December 2020

Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man

1 reference

12 December 2020

Dangers of amiodarone and anticoagulant treatment

1 reference

12 December 2020

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

1 reference

12 December 2020

Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease

1 reference

12 December 2020

Electrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunction

1 reference

12 December 2020

The electrophysiologic effects of oral cibenzoline

1 reference

12 December 2020

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

1 reference

12 December 2020

Antiarrhythmic properties of MJ 9067 in acute animal models

1 reference

12 December 2020

Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Propafenone: a new agent for ventricular arrhythmia

1 reference

12 December 2020

Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias

1 reference

12 December 2020

Electrophysiological effects of sotalol--just another beta blocker?

1 reference

12 December 2020

Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia

1 reference

12 December 2020

Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.

1 reference

12 December 2020

The distribution, metabolism and excretion of mexiletine in man

1 reference

12 December 2020

Mexiletine therapy in 15 patients with drug-resistant ventricular tachycardia.

1 reference

12 December 2020

Treatment of ventricular arrhythmias with mexiletine (Kö 1173).

1 reference

12 December 2020

[Interference in the conversion of T4 to T3 and rT3 by medications in man]

1 reference

12 December 2020

Beware: propafenon potentiates the effect of oral anticoagulants

1 reference

12 December 2020

Mexiletine (Kö 1173) in the management of ventricular dysrhythmias

1 reference

12 December 2020

Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia

1 reference

12 December 2020

CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent

1 reference

12 December 2020

Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine

1 reference

12 December 2020

Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173

1 reference

12 December 2020

Long-Term Sotalol Therapy in Patients with Arrhythmias

1 reference

12 December 2020

Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors

1 reference

12 December 2020

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

1 reference

12 December 2020

Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.

1 reference

12 December 2020

Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia

1 reference

12 December 2020

Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment

1 reference

12 December 2020

Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias

1 reference

12 December 2020

Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias

1 reference

12 December 2020

Pharmacology of amiodarone, and anti-anginal drug with a new biological profile

1 reference

12 December 2020

Propafenon in the treatment of ventricular arrhythmias

1 reference

12 December 2020

Electrophysiologic effects of phenothiazines on canine cardiac fibers.

1 reference

12 December 2020

Amiodarone pulmonary toxicity

1 reference

12 December 2020

Long-term mexiletine for ventricular arrhythmia

1 reference

12 December 2020

Absorption, distribution and elimination of mexiletine

1 reference

12 December 2020

Clinical pharmacology of propafenone

1 reference

12 December 2020

Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias

1 reference

12 December 2020

Kinetics of the oral antiarrhythmie lidocaine congener, tocainide

1 reference

12 December 2020

Pharmacokinetics of amiodarone in man.

1 reference

12 December 2020

Side effects of long-term amiodarone therapy

1 reference

12 December 2020

Mexiletine in the management of ventricular dysrhythmias

1 reference

12 December 2020

Pharmacokinetics of mexiletine in renal insufficiency

1 reference

12 December 2020

Tocainide for refractory ventricular arrhythmias of myocardial infarction

1 reference

12 December 2020

Amiodarone kinetics after oral doses

1 reference

12 December 2020

Plasma level and effectiveness of propafenone and its organ distribution (author's transl)

1 reference

12 December 2020

Pirmenol kinetics and effective oral dose

1 reference

12 December 2020

Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide

1 reference

12 December 2020

Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide

1 reference

12 December 2020

Membrane Action of Ethmozin on Normoxic and Hypoxic Canine Purkinje Fibers

1 reference

12 December 2020

Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia

1 reference

12 December 2020

Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachy

1 reference

12 December 2020

Antiarrhythmic activity of the O-demethyl metabolite of encainide

1 reference

12 December 2020

Antiarrhythmic drug classification: new science and practical applications

1 reference

12 December 2020

Effects of tocainide on left ventricular performance at rest and during acute alterations in heart rate and systemic arterial pressure. An echocardiographic study

1 reference

12 December 2020

Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients

1 reference

12 December 2020

Effect of amiodarone on serum quinidine and procainamide levels

1 reference

12 December 2020

Long-term oral antiarrhythmic therapy with mexiletine

1 reference

12 December 2020

Observations on haemodynamic effects of mexiletine

1 reference

12 December 2020

Further observations on the electrophysiologic effects of oral amiodarone therapy.

1 reference

12 December 2020

Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics

1 reference

12 December 2020

Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease

1 reference

12 December 2020

Metabolism of flecainide

1 reference

12 December 2020

Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and tolerance

1 reference

12 December 2020

Effects of flecainide on contractile force and electrophysiological parameters in cardiac muscle

1 reference

12 December 2020

Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death

1 reference

12 December 2020

Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Effects of flecainide on ventricular function: clinical and experimental correlations.

1 reference

12 December 2020

Amiodarone keratopathy. Correlation to dosage and duration

1 reference

12 December 2020

Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.

1 reference

12 December 2020

Tocainide for refractory symptomatic ventricular arrhythmias.

1 reference

12 December 2020

The potentiation of warfarin anticoagulation by amiodarone

1 reference

12 December 2020

Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies

1 reference

12 December 2020

Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication

1 reference

12 December 2020

Clinical efficacy of amiodarone as an antiarrhythmic agent

1 reference

12 December 2020

Acute hemodynamic effects of intravenous encainide in patients with heart disease.

1 reference

12 December 2020

The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol

1 reference

12 December 2020

Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial

1 reference

12 December 2020

Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.

1 reference

12 December 2020

The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.

1 reference

12 December 2020

A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes

1 reference

12 December 2020

Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone

1 reference

12 December 2020

Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics

1 reference

12 December 2020

Oral flecainide acetate for the treatment of ventricular arrhythmias

1 reference

12 December 2020

Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.

1 reference

12 December 2020

Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction

1 reference

12 December 2020

The adrenergic antagonism of amiodarone

1 reference

12 December 2020

Canine electrophysiology of encainide, a new antiarrhythmic drug

1 reference

12 December 2020

Efficacy of intravenous sotalol on ventricular arrhythmias occurring during maximal exercise stress testing

1 reference

12 December 2020

[Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]

1 reference

12 December 2020

Electrocardiographic and hemodynamic effects of tocainide (W-36095) in man

1 reference

12 December 2020

Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia

1 reference

12 December 2020

Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia

1 reference

12 December 2020

Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular arrhythmias

1 reference

12 December 2020

Antiarrhythmic and haemodynamic effects of mexiletine

1 reference

12 December 2020

A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes

1 reference

12 December 2020

Treatment of ventricular arrhythmias with oral tocainide

1 reference

12 December 2020

Control of ventricular preexcitation and associated arrhythmias by encainide.

1 reference

12 December 2020

Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction.

1 reference

12 December 2020

Encainide for refractory ventricular tachyarrhythmia

1 reference

12 December 2020

Tocainide therapy for refractory ventricular arrhythmias.

1 reference

12 December 2020

Electrophysiological effects of mexiletine in man.

1 reference

12 December 2020

Mexiletine in the prevention of ventricular arrhythmias in acute myocardial infarction

1 reference

12 December 2020

Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias

1 reference

12 December 2020

Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine.

1 reference

12 December 2020

Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction

1 reference

12 December 2020

Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system

1 reference

12 December 2020

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent

1 reference

12 December 2020

Electrophysiologic properties of a new antiarrhythmic drug—Tocainide

1 reference

12 December 2020

The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies

1 reference

12 December 2020

Blunting of Exercise-Induced Tachycardia and Renin Release 24 Hours After a Single Dose of Sotalol

1 reference

12 December 2020

Effects of amiodarone on sinus node in man

1 reference

12 December 2020

Sotalol-induced torsade de pointes

1 reference

12 December 2020

Alveolitis after treatment with amiodarone

1 reference

12 December 2020

Hemodynamic action of propafenon in patients with atherosclerotic coronary disease

1 reference

12 December 2020

Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study

1 reference

12 December 2020

Amiodarone pharmacokinetics

1 reference

12 December 2020

Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Pharmacokinetic evaluation of the digoxin-amiodarone interaction

1 reference

12 December 2020

Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias

1 reference

12 December 2020

New antiarrhythmic drugs: their place in therapy

1 reference

12 December 2020

Lack of effectiveness of oral mexiletine in patients with drug-refractory paroxysmal sustained ventricular tachycardia. A study utilizing programmed stimulation

1 reference

12 December 2020

Amiodarone-induced ventricular tachycardia

1 reference

12 December 2020

Biotransformation of cibenzoline to 2-(2,2-diphenylcyclopropyl)-1H-imidazole

1 reference

12 December 2020

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol

1 reference

12 December 2020

Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia

1 reference

12 December 2020

Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias

1 reference

12 December 2020

Effects of sotalol in twenty patients with cardiac arrhythmias

1 reference

12 December 2020

1 reference

12 December 2020

Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase

1 reference

12 December 2020

Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.

1 reference

12 December 2020

Amiodarone pigmentation. A rare, but typical drug side-effect

1 reference

12 December 2020

Amiodarone dosing: a proposal based on its pharmacokinetics

1 reference

12 December 2020

Haemodynamic studies on mexiletine, anew antiarrhythmic agent

1 reference

12 December 2020

Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug

1 reference

12 December 2020

Amiodarone keratopathy: drug-induced lipid storage disease

1 reference

12 December 2020

Prolongation of the human cardiac monophasic action potential by sotalol

1 reference

12 December 2020

Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias

1 reference

12 December 2020

Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias

1 reference

12 December 2020

Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

1 reference

12 December 2020

Human Electropharmacology of Tocainide, a lidocaine congener

1 reference

12 December 2020

10.2165/00003495-198835030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

13 September 2017

0 references

1 reference